Orbimed Advisors LLC Biom X Inc. Transaction History

Orbimed Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $0.48 $2.59 Million - $4.44 Million	9,256,064 Added 204.89%	13,773,653 $4.68 Million
Q4 2023 Feb 14, 2024	SELL	$0.26 - $0.61 $9,334 - $21,899	-35,900 Reduced 0.79%	4,517,589 $1.26 Million
Q2 2023 Aug 14, 2023	BUY	$0.25 - $0.42 $348,000 - $584,640	1,392,000 Added 44.03%	4,553,489 $1.64 Million
Q1 2023 May 15, 2023	BUY	$0.18 - $0.57 $62,640 - $198,359	348,000 Added 12.37%	3,161,489 $948,000
Q3 2021 Nov 15, 2021	BUY	$30.6 - $58.1 $15.3 Million - $29.1 Million	500,000 Added 21.61%	2,813,489 $8.61 Million
Q4 2019 Feb 14, 2020	BUY	$61.3 - $108.0 $142 Million - $250 Million	2,313,489 New	2,313,489 $22.4 Million

301K

Ticker PHGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,982,300
Market Cap $19.2M
Description
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.